Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs

被引：2
|
作者：
Holden, Sarah E. [1 ]
Bannister, Christian A. [1 ]
Currie, Craig J. [1 ]
机构：
[1] Cardiff Univ, Cardiff Medictr, Pharma Res Ctr, Sch Med, Cardiff CF14 4UJ, S Glam, Wales
来源：
DIABETOLOGIA | 2014年 / 57卷 / 09期
基金：
英国医学研究理事会;
关键词：
Cancer; Diabetes; Diabetes duration; Insulin; Mortality; Treatment;
D O I：
10.1007/s00125-014-3281-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2001 / 2002
页数：2
相关论文
共 50 条
  • [21] Evaluation Approach can Significantly Influence Oral Glucose-Lowering Drugs Total Mortality Risks in Retrospective Cohorts of Type 2 Diabetes Mellitus Patients
    Khalangot, Mykolay
    Kovtun, Volodymir
    CURRENT DIABETES REVIEWS, 2014, 10 (05) : 336 - 342
  • [22] Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19
    Zhu, Zheng
    Zeng, Qingya
    Liu, Qinyu
    Wen, Junping
    Chen, Gang
    JAMA NETWORK OPEN, 2022, 5 (12)
  • [23] Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study
    Vicentini, Massimo
    Ballotari, Paola
    Rossi, Paolo Giorgi
    Venturelli, Francesco
    Sacchettini, Claudio
    Greci, Marina
    Mangone, Lucia
    Pezzarossi, Annamaria
    Manicardi, Valeria
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 398 - 408
  • [24] Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis*
    Li, Jiaxi
    Ji, Cheng
    Zhang, Wen
    Lan, Linyan
    Ge, Weihong
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (01)
  • [25] Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome
    Avogaro, Angelo
    Bonora, Enzo
    Consoli, Agostino
    Del Prato, Stefano
    Genovese, Stefano
    Giorgino, Francesco
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05) : 399 - 414
  • [26] THE GLUCOSE-LOWERING THERAPY STRUCTURE IN SPECIAL GROUPS OF TYPE 2 DIABETES MELLITUS PATIENTS BASED ON DATA FROM THE MOSCOW REGION REGISTER
    Misnikova, Inna, V
    Kovaleva, Yulia A.
    Isakov, Mikhail A.
    Dreval, Alexander, V
    DIABETES MELLITUS, 2019, 22 (03): : 206 - 216
  • [27] Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong
    Luk, Andrea On Yan
    Yip, Terry C. F.
    Zhang, Xinge
    Kong, Alice Pik Shan
    Wong, Vincent Wai-Sun
    Ma, Ronald Ching Wan
    Wong, Grace Lai-Hung
    BMJ OPEN, 2021, 11 (10):
  • [28] Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?
    Jacobsen, Soren L.
    Kohler-Forsberg, Ole
    Rohde, Christopher
    SCHIZOPHRENIA RESEARCH, 2024, 270 : 231 - 234
  • [29] Beneficial effect of sodium-glucose cotransporter-2 inhibitors on mortality among patients with cancer and diabetes mellitus
    Hu, Wei-Syun
    Lin, Cheng-Li
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (04) : 4355 - 4360
  • [30] Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study
    Skurtveit, S.
    Strom, H.
    Skrivarhaug, T.
    Morland, J.
    Bramness, J. G.
    Engeland, A.
    DIABETIC MEDICINE, 2009, 26 (04) : 404 - 408
12345